Delivery Order SPE2DB20D3103-SPE2DB23FN3F1

Award Date 5/8/23
Potential Completion Date 5/9/23
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,535.30 firm-fixed-price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,044.70, is for the delivery of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of November 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $10,010.18 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,294.87, is a Firm Fixed Price Delivery Order for the supply of ABRAXANE 100 MG VIALS, a specialty oncology medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,292.38, is for the delivery of ABRAXANE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,579.04 firm fixed-price delivery order is for the supply of ABRAXANE 100 mg vials, a specialty medication. The contract has a completion date of November 21, 2023 and was awarded on November 20, 2023. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $20,776.50 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract (IDC) previously awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $3,943.32 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp has received numerous prior awards from...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN3F1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,841.20 firm fixed-price delivery order is for 4560863156 ABRAXANE 100 MG VIALS, with a performance period through May 9, 2023.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 5/9/25, 10:12 AM